These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 6409486)
21. Reversible inhibition of thromboxane A2 production by imidazole 2-hydroxybenzoate (ITF 182) in the arachidonic acid injected rat. A comparison with acetylsalicylic acid and indometacin. Pagella PG; Agozzino S; Bellavite O; Donà GC Arzneimittelforschung; 1984; 34(5):597-8. PubMed ID: 6432000 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of platelet thromboxane synthesis by 7-(1-imidazolyl) heptanoic acid: dissociation from inhibition of aggregation. Grimm LJ; Knapp DR; Senator D; Halushka PV Thromb Res; 1981 Nov; 24(4):307-17. PubMed ID: 6801806 [No Abstract] [Full Text] [Related]
23. Prostaglandin and thromboxane synthesis by microsomes of rabbit ocular tissues. Kass MA; Holmberg NJ Invest Ophthalmol Vis Sci; 1979 Feb; 18(2):166-71. PubMed ID: 761971 [TBL] [Abstract][Full Text] [Related]
24. Enhancement of thrombocyte aggregation and thromboxane B2 synthesis by diethylstilbestrol. Subbiah MT; Gallon L; Yunker R Pharmacology; 1980; 21(6):396-9. PubMed ID: 7220591 [TBL] [Abstract][Full Text] [Related]
25. Vascular prostaglandin and thromboxane production in a canine model of myocardial ischemia. Schmitz JM; Apprill PG; Buja LM; Willerson JT; Campbell WB Circ Res; 1985 Aug; 57(2):223-31. PubMed ID: 3926340 [TBL] [Abstract][Full Text] [Related]
26. Effect of cetiedil on platelet aggregation and thromboxane synthesis. Yamaguchi A; Asakura T; Tanoue K; Yamazaki H Thromb Res; 1985 Feb; 37(3):391-400. PubMed ID: 2986312 [TBL] [Abstract][Full Text] [Related]
27. Differences in thromboxane production between neonatal and adult platelets in response to arachidonic acid and epinephrine. Stuart MJ; Dusse J; Clark DA; Walenga RW Pediatr Res; 1984 Sep; 18(9):823-6. PubMed ID: 6435080 [TBL] [Abstract][Full Text] [Related]
28. A dominant role of thromboxane formation in secondary aggregation of platelets. Meyers KM; Seachord CL; Holmsen H; Smith JB; Prieur DJ Nature; 1979 Nov; 282(5736):331-3. PubMed ID: 503210 [No Abstract] [Full Text] [Related]
29. In vitro effects of acetaminophen and its analogues on human platelet aggregation and thromboxane B2 synthesis. Shorr RI; Kao KJ; Pizzo SV; Rauckman EJ; Rosen GM Thromb Res; 1985 Apr; 38(1):33-43. PubMed ID: 3923647 [TBL] [Abstract][Full Text] [Related]
30. Effects of heparin on platelet aggregation and release and thromboxane A2 production. Mohammad SF; Anderson WH; Smith JB; Chuang HY; Mason RG Am J Pathol; 1981 Aug; 104(2):132-41. PubMed ID: 7258300 [TBL] [Abstract][Full Text] [Related]
31. Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung. Bureau MF; De Clerck F; Lefort J; Arreto CD; Vargaftig BB J Pharmacol Exp Ther; 1992 Feb; 260(2):832-40. PubMed ID: 1738127 [TBL] [Abstract][Full Text] [Related]
32. Protection of ischemic cat myocardium by CGS-13080, a selective potent thromboxane A2 synthesis inhibitor. Burke SE; DiCola G; Lefer AM J Cardiovasc Pharmacol; 1983; 5(5):842-7. PubMed ID: 6195474 [TBL] [Abstract][Full Text] [Related]
33. L8027 and 1-nonyl-imidazole as non-selective inhibitors of thromboxane synthesis. Prancan AV; Lefort J; Chignard M; Gerozissis K; Dray F; Vargaftig BB Eur J Pharmacol; 1979 Dec; 60(4):287-97. PubMed ID: 527664 [No Abstract] [Full Text] [Related]
34. Platelet aggregability, thromboxane A2 and malonaldehyde formation following administration of aspirin to man. Szczeklik A; Gryglewski RJ; Grodzińska L; Musiał J; Serwońska M; Marcinkiewicz E Thromb Res; 1979; 15(3-4):405-13. PubMed ID: 494154 [No Abstract] [Full Text] [Related]
35. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance. Frelinger AL; Furman MI; Linden MD; Li Y; Fox ML; Barnard MR; Michelson AD Circulation; 2006 Jun; 113(25):2888-96. PubMed ID: 16785341 [TBL] [Abstract][Full Text] [Related]
36. Platelet aggregation induced by arachidonic acid and thromboxane generation in patients with hypertension or cerebrovascular disease. Matsumoto M; Kusunoki M; Uyama O; Fujisawa A; Matsuyama T; Yoneda S; Kimura K; Abe H Prostaglandins Med; 1981 Dec; 7(6):553-62. PubMed ID: 7323212 [TBL] [Abstract][Full Text] [Related]
37. Platelet aggregation and thromboxane A2 production after adrenergic stimulation in young healthy humans. Neri Serheri GG; Abbate R; Gensini GF; Galanti G; Paoli G; Laureano R Haemostasis; 1982; 11(1):40-8. PubMed ID: 6279476 [TBL] [Abstract][Full Text] [Related]
38. Arachidonic acid-stimulated platelet tests: Identification of patients less sensitive to aspirin treatment. Temperilli F; Rina A; Massimi I; Montemari AL; Guarino ML; Zicari A; Pulcinelli FM Platelets; 2015; 26(8):783-7. PubMed ID: 25734355 [TBL] [Abstract][Full Text] [Related]
39. Effect of platelet-generated thromboxane on contractions of the pregnant rat uterus. Dubin NH; Blake DA; Egner PG; Ghodgaonkar RB Biol Reprod; 1982 Mar; 26(2):289-95. PubMed ID: 7039705 [TBL] [Abstract][Full Text] [Related]